SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001637822-18-000007
Filing Date
2018-08-09
Accepted
2018-08-09 16:19:56
Documents
2
Period of Report
2018-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_153384597921863.html 3  
1 FORM 3 wf-form3_153384597921863.xml 3 1737
2 THOMAS R CANNELL POA sesn-poacannell2.htm EX-24 8737
  Complete submission text file 0001637822-18-000007.txt   11969
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142
Business Address
Cannell Thomas R (Reporting) CIK: 0001637822 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 181005318